LONG PULSED ND:YAG LASER (1064 NM) VERSUS INTENSE PULSED LIGHT IN TREATMENT OF TRAUMATIC AND POST-SURGICAL ERYTHEMATOUS SCARS
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to compare the efficacy and safety of long-pulsed ND:YAG laser and intense pulsed light in the treatment of traumatic and post-surgical erythematous scars. Forty patients presenting with traumatic and post-surgical erythematous scars on the head and neck, of six months' duration or less, were randomly divided into two equal groups. Group A patients received long-pulsed ND:YAG laser sessions, while Group B patients received intense pulsed light sessions. Four sessions were given at four-week intervals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 12, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedMay 20, 2026
April 1, 2026
2.1 years
May 15, 2026
May 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the efficacy and safety of long-pulsed Nd-YAG laser and intense pulsed light in the treatment of traumatic and post-surgical erythematous scars.
The efficacy were assessed using the Patient and Observer scar assessment scale as well as subjective and objective assessment of scar erythema
From enrollment to 3 months after last treatment sessions, where four sessions were given at four-week intervals.
Study Arms (2)
Group A
ACTIVE COMPARATORGroup B
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients of either gender, aged more than 12 years, presenting with an erythematous scar on the head and neck area, traumatic or post-surgical, and of a duration equal to or less than six months.
You may not qualify if:
- \. Patients with post burn scars, scars of more than six months duration, keloids, post acne atrophic erythematous scars or scars that are not located on the head and neck area.
- \. Patients with active bacterial, viral, or fungal cutaneous infection within the scar tissue.
- \. Patients who are pregnant or lactating. 4. Known contraindication to laser therapy. 5. Use of Isotretinoin within the previous 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria main university hospital, Department of dermatology and venerology.
Alexandria, Alexandria Governorate, 55555, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2026
First Posted
May 20, 2026
Study Start
November 16, 2022
Primary Completion
December 25, 2024
Study Completion
April 12, 2025
Last Updated
May 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share